Outcome Measures by Race/Ethnicity
COMPASS Dashboard screen displaying viral suppression or retention in care by race/ethnicity of RWHAP clients.
COMPASS Dashboard screen displaying viral suppression or retention in care by race/ethnicity of RWHAP clients.
COMPASS Dashboard screen displaying viral suppression and retention in care by housing status of RWHAP clients.
COMPASS Dashboard screen displaying RWHAP client viral suppression and retention in care, by transmission category as well as variations among priority populations.
COMPASS Dashboard screen displaying the percentage of RWHAP clients receiving core medical and support services.
COMPASS Dashboard screen displaying demographic characteristics of RWHAP AIDS Drug Assistance Program (ADAP) clients.
COMPASS Dashboard notes and definitions.
Plan de estudios de sesiones educativas para promover la participación y retención del cliente en la atención del VIH a fin de aumentar las tasas generales de supresión viral, con base en prácticas informadas por la evidencia, incluidas entrevistas motivacionales, para abordar las brechas identificadas en la atención.
Resource updated 09/19/2023
RWHAP Technical Assistance Provider updated on 04/15/2024
RWHAP Technical Assistance Provider updated on 04/18/2024
Blog updated 04/10/2023
Blog updated 06/06/2024
This report highlights projects found to offer highly effective (and replicable) approaches to integrating buprenorphine-based medication-assisted treatment into HIV/AIDS primary care. Chapters outline the processes programs need to put in place, including meeting DATA 2000 regulatory requirements, achieving institutional buy-in, implementing staff training requirements, and evaluating processes and outcomes.
Resource updated 04/02/2024
Blog updated 09/06/2022
Table presenting various software systems that are RSR-Ready build.
Resource updated 01/29/2024
Implementation of innovations for End the HIV Epidemic (EHE) efforts requires innovative research/community collaborations. This session presents LA County’s efforts to prepare for long-acting injectable treatment, Miami’s pilot of telemedicine for test-and-treat at a syringe services program, and Philadelphia’s partnership to evaluate a U=U campaign.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023